

























Preoperatively 100% of patients had US, 82 (93%) MIBI and 67 (59%) CT.
Three (3%) had single image modality, 30 (34%) had two and 43 (49%)
had three imaging modalities.
Forty‐three (53%) parathyroid adenomas were identified with US, 39
(52%) with MIBI and 31 (67%) with CT. Combined US/MIBI were carried
out in 82 patients, yielding a sensitivity of 63%. Paired US/CT had a
sensitivity of 75% in 52 patients. These findings are illustrated in Tables 2
and 3 respectively.
Conclusion
In the absence of SPECT, combined USS/CT was superior for accurate
preoperative localisation of solitary parathyroid adenomas over any
single or combined imaging modality.
Introduction
Primary hyperparathyroidism (PHPT) is caused by a solitary benign
adenoma in 80‐85% of cases, but may also be due to multi‐gland or
ectopic disease, hyperplasia, and rarely parathyroid carcinoma.
Preoperative localisation studies are important to identify patients
suitable for minimally invasive parathyroid surgery.
The aim of this study was to evaluate the accuracy of ultrasound (US),
parathyroid scintigraphy (MIBI) and computed tomography (CT) utilised
in the preoperative setting in a district general hospital, with limited
access to single photon‐emission computed tomography (SPECT).
Methods
A retrospective study of 88 consecutive patients, who underwent
parathyroidectomy for PHPT at a single unit between 2010 and 2014,
was conducted. Patients were identified using discharge codes from
locally held coding data. The sensitivity and specificity of each imaging
modality was compared against histology as the gold standard.
Results
Eighty‐eight patients (female to male ratio 5.8:1 and mean age
61.5±11.3 years) were studied. Eighty‐two (93%) patients were first
presentations of PHPT and six (7%) were relapses, requiring remedial
surgery. At surgery, a solitary adenoma was identified in 72 (82%)
patients; eight (9%) had parathyroid hyperplasia and one (1%) had
parathyroid carcinoma. Clinical characteristics of the study population
are summarised below in Table 1.
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Table 2. Summary of the sensitivities and specificities with associated 95% confidence
intervals (CIs), for each of the 4 methods assessed on an individual basis.
Figure 1. shows the location of
the abnormal gland at surgery. Y‐
axis represents frequency.
METHOD SENSITIVITY SPECIFICITY
Best estimate 95% CI Best estimate 95% CI
USS
53.1% (43/81) (42.2%, 64.0%) 87.5% (7/8) (64.6%, 100.0%)
MIBI
52.0% (39/75) (40.7%, 63.3%) 87.5% (7/8) (64.6%, 100.0%)
CT
67.4% (31/46) (53.8%, 80.9%) 85.7% (6/7) (59.7%, 100.0%)
SPECT 76.9% (10/13) (54.0%, 99.8%) 85.7% (6/7) (59.7%, 100.0%)
Figure 2. shows the total number
of imaging modalities utilised
Table 1. Summary of clinical characteristics of patients with parathyroidectomy (n=88).
Table 3. Summary of the sensitivities and specificities with associated 95% confidence
intervals (CIs), of each of the 6 combined pairs of methods assessed on an individual basis.
METHODS SENSITIVITY SPECIFICITY
Best estimate 95% CI Best estimate 95% CI
USS + SPECT 85.7% (18/21) (70.7%, 100.0%) 71.4% (5/7) (38.0%, 100.0%)
USS + CT 74.5% (35/47) (62.0%, 86.9%) 100.0% (6/6) ‐
MIBI + SPECT 70.0% (7/10) (41.6%, 98.4%) 71.4% (5/7) (38.0%, 100.0%)
USS + MIBI 62.7% (47/75) (51.7%, 73.6%) 83.3% (5/6) (53.6%, 100.0%)
CT + SPECT 50.0% (3/6) (10.0%, 90.0%) 83.3% (5/6) (53.6%, 100.0%)
CT + MIBI 47.1% (33/70) (35.4%, 58.8%) 100.0% (6/6) ‐
